News Room

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Envision Healthcare Holdings Inc (NYSE: EVHC) acted responsibly on behalf of investors’ profitability in the planned $4.73 billion sale to AmSurg Corporation (NASDAQ: AMSG). […]

06-22-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of ChromaDex Corporation (NASDAQ: CDXC) violated securities laws in connection with certain financial statements. […]

06-22-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of American Science and Engineering Inc (NASDAQ: ASEI) acted responsibly on behalf of investors’ profitability in the planned $269 million sale to OSI Systems Inc (NASDAQ: OSIS). […]

06-22-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of E*TRADE Financial Corp (NASDAQ: ETFC) violated securities laws in connection with certain financial statements. […]

06-21-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Signet Jewelers Limited (NYSE:SIG) violated securities laws in connection with certain financial statements. […]

06-21-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Marketo Inc (NASDAQ: MKTO) acted responsibly on behalf of investors’ profitability in the planned $1.79 billion sale to Vista Equity Partners. […]

06-20-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Axiall Corporation (NYSE: AXLL) acted responsibly on behalf of investors’ profitability in the planned $3.8 billion sale to Westlake Chemical Corporation (NYSE: WLK). […]

06-20-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Insmed Incorporated (NASDAQ:INSM) violated securities laws in connection with certain financial statements. […]

06-20-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Infinity Pharmaceuticals Inc (NASDAQ: INFI) violated securities laws in connection with certain financial statements. […]

06-20-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of LinkedIn Corporation (NYSE: LNKD) acted responsibly on behalf of investors’ profitability in the planned $26.2 billion sale to Microsoft Corporation (NASDAQ: MSFT). […]

06-17-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of LDR Holding Corporation (NASDAQ: LDRH) acted responsibly on behalf of investors’ profitability in the planned $1.0 billion sale to Zimmer Biomet Holdings Inc (NYSE: ZBH). […]

06-17-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Elizabeth Arden Inc (NASDAQ: RDEN) acted responsibly on behalf of investors’ profitability in the planned $870 million sale to Revlon Inc (NYSE: REV). […]

06-17-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of QLogic Corporation (NASDAQ: QLGC) acted responsibly on behalf of investors’ profitability in the planned $1.36 billion sale to Cavium Inc (NASDAQ: CAVM). […]

06-17-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Gilead Sciences Inc (NASDAQ: GILD) violated securities laws in connection with certain financial statements. […]

06-15-2016

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of FEI Company (NASDAQ: FEIC) acted responsibly on behalf of investors’ profitability in the planned $4.2 billion sale to Thermo Fisher Scientific Inc (NYSE: TMO). […]

06-15-2016